Evaluating agreement regarding the resectability of colorectal liver metastases: A national case-based survey of hepatic surgeons

HPB

Volumn 14, Issue 5, 2012, Pages 291-297

  Mohammad, Waleed M ^a   Martel, Guillaume ^a   Mimeault, Richard ^a   Fairfull Smith, Robert J ^a   Auer, Rebecca C ^a   Balaa, Fady K ^a  

^a UNIVERSITY OF OTTAWA   (Canada)

Author keywords

colorectal cancer; consensus; liver metastasis; multidisciplinary conference; resectability; tumour board

Indexed keywords

ANTINEOPLASTIC AGENT;

CANADA; CANCER ADJUVANT THERAPY; COLORECTAL CANCER; COLORECTAL LIVER METASTASIS; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; HUMAN; LIVER METASTASIS; LIVER RESECTION; METASTASIS RESECTION; MULTIMODALITY CANCER THERAPY; MULTIPLE CYCLE TREATMENT; REVIEW; SURGEON; TREATMENT RESPONSE;

EID: 84859700899     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/j.1477-2574.2012.00440.x     Document Type: Article

References (28)

1. Jemal A, Siegel R, Xu J, Ward E,. (2010) Cancer statistics, 2010. CA Cancer J Clin 60: 277-300.
2. Steele G Jr, Ravikumar TS,. (1989) Resection of hepatic metastases from colorectal cancer. Biologic perspective. Ann Surg 210: 127-138. (Pubitemid 19188702)
3. Fong Y, Fortner J, Sun RL, Brennan MF, Blumgart LH,. (1999) Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases. Ann Surg 230: 309-318.
4. Choti MA, Sitzmann JV, Tiburi MF, Sumetchotimetha W, Rangsin R, Schulick RD, et al,. (2002) Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 235: 759-766. (Pubitemid 34547293)
5. Abdalla EK, Vauthey JN, Ellis LM, Ellis V, Pollock R, Broglio KR, et al,. (2004) Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239: 818-825.
6. Vigano L, Ferrero A, Lo Tesoriere R, Capussotti L,. (2008) Liver surgery for colorectal metastases: results after 10 years of follow-up. Long-term survivors, late recurrences, and prognostic role of morbidity. Ann Surg Oncol 15: 2458-2464.
7. Adam R, Delvart V, Pascal G, Valeanu A, Castaing D, Azoulay D, et al,. (2004) Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival. Ann Surg 240: 644-657.
8. Charnsangavej C, Clary B, Fong Y, Grothey A, Pawlik TM, Choti MA,. (2006) Selection of patients for resection of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 13: 1261-1268. (Pubitemid 44435791)
9. Ekberg H, Tranberg KG, Andersson R, Lundstedt C, Hägerstrand I, Ranstam J, et al,. (1986) Determinants of survival in liver resection for colorectal secondaries. Br J Surg 73: 727-731. (Pubitemid 16011176)
10. Bismuth H, Adam R, Levi F, Farabos C, Waechter F, Castaing D, et al,. (1996) Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. Ann Surg 224: 509-520.
11. Figueras J, Torras J, Valls C, Llado L, Ramos E, Marti-Raque J, et al,. (2007) Surgical resection of colorectal liver metastases in patients with expanded indications: a single-center experience with 501 patients. Dis Colon Rectum 50: 478-488. (Pubitemid 46701611)
12. Pawlik TM, Choti MA,. (2007) Surgical therapy for colorectal metastases to the liver. J Gastrointest Surg 11: 1057-1077.
13. Garden OJ, Rees M, Poston GJ, Mirza D, Saunders M, Ledermann J, et al,. (2006) Guidelines for resection of colorectal cancer liver metastases. Gut 55 (Suppl 3): iii1-iii8. (Pubitemid 44085662)
14. Leake PA, Urbach DR,. (2010) Measuring processes of care in general surgery: assessment of technical and nontechnical skills. Surg Innov 17: 332-339.
15. Bipat S, van Leeuwen MS, Oyen WJ, Planting AS, Ijermans JN, Stoker J,. (2008) Imaging in the diagnosis of colorectal liver metastases and extrahepatic abnormalities. Ned Tijdschr Geneeskd 152: 857-862. (Pubitemid 351553409)
16. Kamel IR, Choti MA, Horton KM, Braga HJ, Birnbaum BA, Fishman EK, et al,. (2003) Surgically staged focal liver lesions: accuracy and reproducibility of dual-phase helical CT for detection and characterization. Radiology 227: 752-757. (Pubitemid 36583032)
17. Scheele J, Stangl R, Altendorf-Hofmann A,. (1990) Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg 77: 1241-1246.
18. Rougier P, Milan C, Lazorthes F, Fourtanier G, Partensky C, Baumel H, et al,. (1995) Prospective study of prognostic factors in patients with unresected hepatic metastases from colorectal cancer. Fondation Francaise de Cancerologie Digestive. Br J Surg 82: 1397-1400.
19. Pestana C, Reitemeier RJ, Moertel CG, Judd ES, Dockerty MB,. (1964) The natural history of carcinoma of the colon and rectum. Am J Surg 108: 826-829.
20. Segelman J, Singnomklao T, Hellborg H, Martling A,. (2009) Differences in multidisciplinary team assessment and treatment between patients with stage IV colon and rectal cancer. Colorectal Dis 11: 768-774.
21. Delaunoit T, Alberts SR, Sargent DJ, Green E, Goldberg RM, Krook J, et al,. (2005) Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741. Ann Oncol 16: 425-429. (Pubitemid 40458319)
22. Giacchetti S, Itzhaki M, Gruia G, Adam R, Zidani R, Kunstlinger F, et al,. (1999) Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. Ann Oncol 10: 663-669. (Pubitemid 29342371)
23. Barone C, Nuzzo G, Cassano A, Basso M, Schinzari G, Giuliante D, et al,. (2007) Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases. Br J Cancer 97: 1035-1039. (Pubitemid 47587006)
24. Clavereo-Fabri MC, Mitry E, Chidiac J, Douillard JY, Meeus P, Raoul JL, et al,. (2003) Results of surgery for liver metastases (LM) after neoadjuvant chemotherapy (CT) with irinotecan + infusional fluorouracil/leucovorin (Iri-FU/LV) in patients (pts) with colorectal cancer (CRC). Proc Am Soc Clin Oncol 22: 1365a.
25. Alberts SR, Horvath WL, Sternfeld WC, Goldberg RM, Mahoney MR, Dakhil SR, et al,. (2005) Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study. J Clin Oncol 23: 9243-9249.
26. Pozzo C, Basso M, Cassano A, Quirino M, Schinzari G, Triglia N, et al,. (2004) Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients. Ann Oncol 15: 933-939. (Pubitemid 39004350)
27. Borner MM,. (1999) Neoadjuvant chemotherapy for unresectable liver metastases of colorectal cancer-too good to be true? Ann Oncol 10: 623-626. (Pubitemid 29342365)
28. Folprecht G, Gruenberger T, Bechstein WO, Raab HR, Lordick F, Hartmann JT, et al,. (2010) Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial. Lancet Oncol 11: 38-47.